116 related articles for article (PubMed ID: 1445996)
1. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[3-(1-methoxy-carbonyl-4-substituted-1,4- dihydro-pyridyl)]-3,5-pyridinedicarboxylates.
Ramesh M; Matowe WC; Knaus EE; Wolowyk MW
Drug Des Discov; 1992 Jul; 8(4):313-23. PubMed ID: 1445996
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[4-(1-methoxycarbonyl-1,4-dihydropyridyl)]-3 ,5- pyridinedicarboxylates.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Arch Pharm (Weinheim); 1999 Nov; 332(11):385-8. PubMed ID: 10605379
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1-oxido-2-pyridyl in place of the 2-nitrophenyl moiety.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Dec; 3(4):337-41. PubMed ID: 3255335
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent.
Davood A; Khodarahmi G; Alipour E; Dehpour K; Amini M; Shafiee A
Boll Chim Farm; 2001; 140(6):381-6. PubMed ID: 11822226
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety.
Soboleski DA; Li-Kwong-Ken MC; Wynn H; Triggle CR; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Feb; 2(3):177-89. PubMed ID: 2855573
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and calcium channel antagonist activity of alkyl cycloalkyl esters of nifedipine containing pyridinyl substituents.
Akula MR; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1989 Dec; 5(2):117-23. PubMed ID: 2577981
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
Anana RD; Ng H; Howlett SE; Knaus EE
Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4-pyridyl and 3-arylethyloxycarbonyl substituents.
Akula MR; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1990 Dec; 7(1):11-7. PubMed ID: 2096831
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine.
Wynn H; Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Nov; 3(3):245-56. PubMed ID: 2855579
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-3,5-pyridinedicarboxylates.
Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Wynn H; Triggle CR; Knaus EE
J Med Chem; 1986 Dec; 29(12):2524-9. PubMed ID: 3783612
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and calcium channel antagonist activity of alkyl t-butyl esters of nifedipine analogues containing pyridinyl substituents.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1987 Dec; 2(2):79-89. PubMed ID: 2855571
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and calcium channel antagonist activity of 3-arylmethyl 5-isopropyl 1,4-dihydro-2,6-dimethyl-4-(pyridyl)-3,5-pyridinedicarboxylates.
Akula MR; Matowe WC; Wolowyk MW; Knaus EE
Pharm Res; 1990 Sep; 7(9):919-22. PubMed ID: 2235890
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and calcium channel antagonist activity of dialkyl 4- (dihydropyridinyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylates.
Dagnino L; Li-Kwong-Ken MC; Wynn H; Wolowyk MW; Triggle CR; Knaus EE
J Med Chem; 1987 Apr; 30(4):640-6. PubMed ID: 3560157
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and activity of 1,4-dihydropyridine analogues of histamine H2-receptor antagonists.
Agrawal VK; Tang SB; Wolowyk MW; Knaus EE
Drug Des Deliv; 1990 Jun; 6(2):101-9. PubMed ID: 1981971
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and smooth muscle calcium channel antagonist effects of alkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-5-[2-(4,5-dihydro- 4,4-dimethyloxazolin-2-yl)]-3-pyridinecarboxylates.
Anana RD; Knaus EE
Arch Pharm (Weinheim); 1996; 329(8-9):408-12. PubMed ID: 8915102
[TBL] [Abstract][Full Text] [Related]
20. Enantioselective syntheses and calcium channel modulating effects of (+)- and (-)-3-isopropyl 5-(4-methylphenethyll) 1,4-dihydro-2,6-dimethyl-4-(2-pyridyl)-3,5-pyridinedicarboxylates.
Iqbal N; Vo D; McEwen CA; Wolowyk MW; Knaus EE
Chirality; 1994; 6(7):515-20. PubMed ID: 7986665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
